Tofacitinib searching
Top keyword related from Search Engine of tofacitinib
Top URL related to tofacitinib
-
1. Tofacitinib: Uses, Dosage, Side Effects, Warnings - Drugs.com
drugs.com
Link: https://www.drugs.com/tofacitinib.html
Description: WEBAug 23, 2023 · Tofacitinib is a prescription medication called a janus kinase (JAK) inhibitor. It is a disease modifying anti-rheumatic drug (DMARD), which works by suppressing the immune system. Tofacitinib is available in the form of a tablet (Xeljanz), an extended release tablet (Xeljanz XR) and as an oral solution.
-
2. Tofacitinib - Wikipedia
wikipedia.org
Link: https://en.wikipedia.org/wiki/Tofacitinib
Description: WEBTofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis, and ulcerative colitis.
-
3. Tofacitinib: MedlinePlus Drug Information
medlineplus.gov
Link: https://medlineplus.gov/druginfo/meds/a613025.html
Description: WEBTofacitinib is used alone or with other medications to treat rheumatoid arthritis (condition in which the body attacks its own joints causing pain, swelling, and loss of function) in adults who are unable to take or did not respond to one or more tumor necrosis factor (TNF) inhibitor medication (s).
-
4. Tofacitinib - StatPearls - NCBI Bookshelf
nih.gov
Link: https://www.ncbi.nlm.nih.gov/books/NBK572148/
Description: WEBJul 3, 2023 · Tofacitinib is FDA approved for the treatment of moderate to severe rheumatoid arthritis (RA), psoriatic arthritis (PA), ulcerative colitis (UC), and polyarticular course juvenile idiopathic arthritis (pcJIA). It is a second-generation selective Janus kinase (JAK) inhibitor targeting the JAK1 enzyme.
-
5. Tofacitinib (Oral Route) Description and Brand Names - Mayo Clinic
mayoclinic.org
Link: https://www.mayoclinic.org/drugs-supplements/tofacitinib-oral-route/description/drg-20075863
Description: WEBTofacitinib is used alone or together with other medicines (eg, DMARDs) to treat moderate to severely active rheumatoid arthritis, active psoriatic arthritis, ulcerative colitis, ankylosing spondylitis, and polyarticular course juvenile idiopathic arthritis (pcJIA) in patients who have taken other medicines (eg, methotrexate) that did not work ...
-
6. Xeljanz (Tofacitinib): Uses & Side Effects - Cleveland Clinic
clevelandclinic.org
Link: https://my.clevelandclinic.org/health/drugs/18147-tofacitinib-oral-tablets
Description: WEBTOFACITINIB (TOE fa SYE ti nib) treats rheumatoid arthritis, psoriatic arthritis, and polyarticular juvenile idiopathic arthritis. It is also used to treat ankylosing spondylitis and ulcerative colitis. It works on the immune system. It belongs to a …
-
7. Tofacitinib: Uses, Interactions, Mechanism of Action | DrugBank …
drugbank.com
Link: https://go.drugbank.com/drugs/DB08895
Description: WEBTofacitinib is indicated for the treatment of adult patients with moderately-to-severely active rheumatoid arthritis (RA), active psoriatic arthritis, active ankylosing spondylitis, or moderately-to-severely active ulcerative colitis who have had an inadequate response or intolerance to one or more TNF blockers. 5 It is also indicated as an ...
-
8. Xeljanz: Uses, Side Effects, Warnings - Drugs.com
drugs.com
Link: https://www.drugs.com/xeljanz.html
Description: WEBXeljanz (tofacitinib) is a biologic medicine classified as Janus kinus (JAK) inhibitor and is used in the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and ulcerative colitis in adults and for polyarticular juvenile idiopathic arthritis in patients 2 …
-
9. tofacitinib oral - Uses, Side Effects, and More - WebMD
webmd.com
Link: https://www.webmd.com/drugs/2/drug-162858-1509/tofacitinib-oral/tofacitinib-oral/details
Description: WEBTofacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis, polyarticular course juvenile idiopathic arthritis -pcJIA)....
-
10. Tofacitinib is first oral medication approved for use in treating
mayoclinic.org
Link: https://www.mayoclinic.org/medical-professionals/digestive-diseases/news/tofacitinib-is-first-oral-medication-approved-for-use-in-treating-moderate-to-severe-ulcerative-colitis/mac-20437782
Description: WEBTofacitinib is first oral medication approved for use in treating moderate to severe ulcerative colitis - Mayo Clinic. Care at Mayo Clinic. Patient-Centered Care. About Mayo Clinic. Request Appointment. Find a Doctor. Locations. Clinical Trials. Connect to Support Groups. Patient & Visitor Guide. Insurance & Billing. Departments & Centers.